Osteoclasts in arthritis and Th17 cell development

International Immunopharmacology

Volumn 11, Issue 5, 2011, Pages 543-548

  Okamoto, Kazuo ^a,b   Takayanagi, Hiroshi ^a,b  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

I B ; Osteoclasts; RANKL; Rheumatoid arthritis; ROR t

Indexed keywords

I KAPPA B; INTERLEUKIN 17; OSTEOCLAST DIFFERENTIATION FACTOR;

ARTICLE; BONE DESTRUCTION; BONE MATRIX; CELL ACTIVATION; CELL DIFFERENTIATION; CYTOKINE PRODUCTION; HUMAN; IMMUNOREGULATION; NONHUMAN; OSTEOCLAST; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS; SYNOVIOCYTE; TH17 CELL;

ANIMALS; ARTHRITIS, RHEUMATOID; BONE RESORPTION; CELL DIFFERENTIATION; HUMANS; INFLAMMATION; INTERLEUKIN-17; OSTEOCLASTS; RANK LIGAND; SIGNAL TRANSDUCTION; SYNOVIAL MEMBRANE; TH17 CELLS;

EID: 79954634320     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2010.11.010     Document Type: Article

References (72)

1. E. Seeman, and P.D. Delmas Bone quality-the material and structural basis of bone strength and fragility N Engl J Med 354 2006 2250 2261
2. H. Takayanagi Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems Nat Rev Immunol 7 2007 292 304 (Pubitemid 46480961)
3. Y. Okada, H. Nagase, and E.D. Harris Jr. Matrix metalloproteinases 1, 2, and 3 from rheumatoid synovial cells are sufficient to destroy joints Spec No: J Rheumatol 14 1987 41 42 (Pubitemid 17139517)
4. N. Takahashi, T. Akatsu, N. Udagawa, T. Sasaki, A. Yamaguchi, and J.M. Moseley Osteoblastic cells are involved in osteoclast formation Endocrinology 123 1988 2600 2602
5. N. Takahashi, H. Yamana, S. Yoshiki, G.D. Roodman, G.R. Mundy, and S.J. Jones Osteoclast-like cell formation and its regulation by osteotropic hormones in mouse bone marrow cultures Endocrinology 122 1988 1373 1382 (Pubitemid 18091966)
6. T. Suda, N. Takahashi, N. Udagawa, E. Jimi, M.T. Gillespie, and T.J. Martin Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families Endocr Rev 20 1999 345 357 (Pubitemid 30649812)
7. H. Yoshida, S. Hayashi, T. Kunisada, M. Ogawa, S. Nishikawa, and H. Okamura The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene Nature 345 1990 442 444 (Pubitemid 120014957)
8. E. Lagasse, and I.L. Weissman Enforced expression of Bcl-2 in monocytes rescues macrophages and partially reverses osteopetrosis in op/op mice Cell 89 1997 1021 1031 (Pubitemid 127678736)
9. H. Yasuda, N. Shima, N. Nakagawa, K. Yamaguchi, M. Kinosaki, and S. Mochizuki Osteoclast differentiation factor is a ligand for osteoprotegerin/ osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL Proc Natl Acad Sci USA 95 1998 3597 3602
10. D.L. Lacey, E. Timms, H.L. Tan, M.J. Kelley, C.R. Dunstan, and T. Burgess Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation Cell 93 1998 165 176 (Pubitemid 28180851)
11. D.M. Anderson, E. Maraskovsky, W.L. Billingsley, W.C. Dougall, M.E. Tometsko, and E.R. Roux A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function Nature 390 1997 175 179 (Pubitemid 27507987)
12. B.R. Wong, J. Rho, J. Arron, E. Robinson, J. Orlinick, and M. Chao TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells J Biol Chem 272 1997 25190 25194 (Pubitemid 27415705)
13. L.E. Theill, W.J. Boyle, and J.M. Penninger RANK-L and RANK: T cells, bone loss, and mammalian evolution Annu Rev Immunol 20 2002 795 823 (Pubitemid 34293440)
14. W.S. Simonet, D.L. Lacey, C.R. Dunstan, M. Kelley, M.S. Chang, and R. Luthy Osteoprotegerin: a novel secreted protein involved in the regulation of bone density Cell 89 1997 309 319 (Pubitemid 27199902)
15. E. Tsuda, M. Goto, S. Mochizuki, K. Yano, F. Kobayashi, and T. Morinaga Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis Biochem Biophys Res Commun 234 1997 137 142 (Pubitemid 27267548)
16. Y.Y. Kong, H. Yoshida, I. Sarosi, H.L. Tan, E. Timms, and C. Capparelli OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis Nature 397 1999 315 323
17. W.C. Dougall, M. Glaccum, K. Charrier, K. Rohrbach, K. Brasel, and T. De Smedt RANK is essential for osteoclast and lymph node development Genes Dev 13 1999 2412 2424 (Pubitemid 29453612)
18. J. Li, I. Sarosi, X.Q. Yan, S. Morony, C. Capparelli, and H.L. Tan RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism Proc Natl Acad Sci USA 97 2000 1566 1571 (Pubitemid 30118482)
19. N. Bucay, I. Sarosi, C.R. Dunstan, S. Morony, J. Tarpley, and C. Capparelli osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification Genes Dev 12 1998 1260 1268 (Pubitemid 28213402)
20. A. Mizuno, N. Amizuka, K. Irie, A. Murakami, N. Fujise, and T. Kanno Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin Biochem Biophys Res Commun 247 1998 610 615 (Pubitemid 28418439)
21. A.E. Hughes, S.H. Ralston, J. Marken, C. Bell, H. MacPherson, and R.G. Wallace Mutations in TNFRSF11A, affecting the signal peptide of RANK, cause familial expansile osteolysis Nat Genet 24 2000 45 48 (Pubitemid 30041418)
22. M.P. Whyte, S.E. Obrecht, P.M. Finnegan, J.L. Jones, M.N. Podgornik, and W.H. McAlister Osteoprotegerin deficiency and juvenile Paget's disease N Engl J Med 347 2002 175 184 (Pubitemid 34764821)
23. C. Sobacchi, A. Frattini, M.M. Guerrini, M. Abinun, A. Pangrazio, and L. Susani Osteoclast-poor human osteopetrosis due to mutations in the gene encoding RANKL Nat Genet 39 2007 960 962 (Pubitemid 47185178)
24. M.M. Guerrini, C. Sobacchi, B. Cassani, M. Abinun, S.S. Kilic, and A. Pangrazio Human osteoclast-poor osteopetrosis with hypogammaglobulinemia due to TNFRSF11A (RANK) mutations Am J Hum Genet 83 2008 64 76 (Pubitemid 351916706)
25. M.A. Lomaga, W.C. Yeh, I. Sarosi, G.S. Duncan, C. Furlonger, and A. Ho TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling Genes Dev 13 1999 1015 1024 (Pubitemid 29200984)
26. A. Naito, S. Azuma, S. Tanaka, T. Miyazaki, S. Takaki, and K. Takatsu Severe osteopetrosis, defective interleukin-1 signalling and lymph node organogenesis in TRAF6-deficient mice Genes Cells 4 1999 353 362 (Pubitemid 29359450)
27. E.F. Wagner, and R. Eferl Fos/AP-1 proteins in bone and the immune system Immunol Rev 208 2005 126 140 (Pubitemid 41746389)
28. K. Sato, A. Suematsu, T. Nakashima, S. Takemoto-Kimura, K. Aoki, and Y. Morishita Regulation of osteoclast differentiation and function by the CaMK-CREB pathway Nat Med 12 2006 1410 1416 (Pubitemid 44924500)
29. T. Yamashita, Z. Yao, F. Li, Q. Zhang, I.R. Badell, and E.M. Schwarz NF-κB p50 and p52 regulate receptor activator of NF-κB ligand (RANKL) and tumor necrosis factor-induced osteoclast precursor differentiation by activating c-Fos and NFATc1 J Biol Chem 282 2007 18245 18253 (Pubitemid 47100255)
30. H. Takayanagi, S. Kim, T. Koga, H. Nishina, M. Isshiki, and H. Yoshida Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts Dev Cell 3 2002 889 901 (Pubitemid 35460788)
31. M. Asagiri, K. Sato, T. Usami, S. Ochi, H. Nishina, and H. Yoshida Autoamplification of NFATc1 expression determines its essential role in bone homeostasis J Exp Med 202 2005 1261 1269 (Pubitemid 41586956)
32. M.M. Winslow, M. Pan, M. Starbuck, E.M. Gallo, L. Deng, and G. Karsenty Calcineurin/NFAT signaling in osteoblasts regulates bone mass Dev Cell 10 2006 771 782 (Pubitemid 43779111)
33. A.O. Aliprantis, Y. Ueki, R. Sulyanto, A. Park, K.S. Sigrist, and S.M. Sharma NFATc1 in mice represses osteoprotegerin during osteoclastogenesis and dissociates systemic osteopenia from inflammation in cherubism J Clin Invest 118 2008 3775 3789
34. T. Koga, M. Inui, K. Inoue, S. Kim, A. Suematsu, and E. Kobayashi Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis Nature 428 2004 758 763 (Pubitemid 38508286)
35. A. Mocsai, M.B. Humphrey, J.A. Van Ziffle, Y. Hu, A. Burghardt, and S.C. Spusta The immunomodulatory adapter proteins DAP12 and Fc receptor γ-chain (FcRγ) regulate development of functional osteoclasts through the Syk tyrosine kinase Proc Natl Acad Sci USA 101 2004 6158 6163 (Pubitemid 38520544)
36. M. Shinohara, T. Koga, K. Okamoto, S. Sakaguchi, K. Arai, and H. Yasuda Tyrosine kinases Btk and Tec regulate osteoclast differentiation by linking RANK and ITAM signals Cell 132 2008 794 806 (Pubitemid 351312796)
37. 2+-NFATc1 signaling is an essential axis of osteoclast differentiation Immunol Rev 231 2009 241 256
38. M. Bromley, and D.E. Woolley Chondroclasts and osteoclasts at subchondral sites of erosion in the rheumatoid joint Arthritis Rheum 27 1984 968 975 (Pubitemid 14004758)
39. H. Takayanagi, H. Oda, S. Yamamoto, H. Kawaguchi, S. Tanaka, and T. Nishikawa A new mechanism of bone destruction in rheumatoid arthritis: synovial fibroblasts induce osteoclastogenesis Biochem Biophys Res Commun 240 1997 279 286 (Pubitemid 27523651)
40. E.M. Gravallese, C. Manning, A. Tsay, A. Naito, C. Pan, and E. Amento Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor Arthritis Rheum 43 2000 250 258 (Pubitemid 30395732)
41. H. Takayanagi, H. Iizuka, T. Juji, T. Nakagawa, A. Yamamoto, and T. Miyazaki Involvement of receptor activator of nuclear factor κB ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis Arthritis Rheum 43 2000 259 269 (Pubitemid 30395733)
42. A.R. Pettit, H. Ji, D. von Stechow, R. Muller, S.R. Goldring, and Y. Choi TRANCE/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritis Am J Pathol 159 2001 1689 1699 (Pubitemid 33062512)
43. K. Redlich, S. Hayer, R. Ricci, J.P. David, M. Tohidast-Akrad, and G. Kollias Osteoclasts are essential for TNF-α-mediated joint destruction J Clin Invest 110 2002 1419 1427 (Pubitemid 35396913)
44. Y.Y. Kong, U. Feige, I. Sarosi, B. Bolon, A. Tafuri, and S. Morony Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand Nature 402 1999 304 309 (Pubitemid 129516268)
45. H. Takayanagi, T. Juji, T. Miyazaki, H. Iizuka, T. Takahashi, and M. Isshiki Suppression of arthritic bone destruction by adenovirus-mediated csk gene transfer to synoviocytes and osteoclasts J Clin Invest 104 1999 137 146
46. H. Takayanagi Osteoimmunology and the effects of the immune system on bone Nat Rev Rheumatol 5 2009 667 676
47. N.J. Horwood, V. Kartsogiannis, J.M. Quinn, E. Romas, T.J. Martin, and M.T. Gillespie Activated T lymphocytes support osteoclast formation in vitro Biochem Biophys Res Commun 265 1999 144 150
48. + T cell lineage differentiation Immunity 30 2009 646 655
49. G.S. Firestein, and N.J. Zvaifler How important are T cells in chronic rheumatoid synovitis? Arthritis Rheum 33 1990 768 773 (Pubitemid 20205755)
50. H. Takayanagi, K. Ogasawara, S. Hida, T. Chiba, S. Murata, and K. Sato T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-γ Nature 408 2000 600 605
51. B. Manoury-Schwartz, G. Chiocchia, N. Bessis, O. Abehsira-Amar, F. Batteux, and S. Muller High susceptibility to collagen-induced arthritis in mice lacking IFN-γ receptors J Immunol 158 1997 5501 5506 (Pubitemid 127681259)
52. K. Vermeire, H. Heremans, M. Vandeputte, S. Huang, A. Billiau, and P. Matthys Accelerated collagen-induced arthritis in IFN-γ receptor-deficient mice J Immunol 158 1997 5507 5513 (Pubitemid 127681260)
53. K. Sato, and H. Takayanagi Osteoclasts, rheumatoid arthritis, and osteoimmunology Curr Opin Rheumatol 18 2006 419 426 (Pubitemid 44297289)
54. H. Takayanagi Inflammatory bone destruction and osteoimmunology J Periodontal Res 40 2005 287 293 (Pubitemid 40977302)
55. R.A. Kastelein, C.A. Hunter, and D.J. Cua Discovery and biology of IL-23 and IL-27: related but functionally distinct regulators of inflammation Annu Rev Immunol 25 2007 221 242 (Pubitemid 46697908)
56. T. Korn, E. Bettelli, M. Oukka, and V.K. Kuchroo IL-17 and Th17 cells Annu Rev Immunol 27 2009 485 517
57. H17 cells in development: an updated view of their molecular identity and genetic programming Nat Rev Immunol 8 2008 337 348 (Pubitemid 351595217)
58. K. Sato, A. Suematsu, K. Okamoto, A. Yamaguchi, Y. Morishita, and Y. Kadono Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction J Exp Med 203 2006 2673 2682 (Pubitemid 44833343)
59. S. Kotake, N. Udagawa, N. Takahashi, K. Matsuzaki, K. Itoh, and S. Ishiyama IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis J Clin Invest 103 1999 1345 1352 (Pubitemid 29218305)
60. + T helper cells Cell 126 2006 1121 1133 (Pubitemid 44380299)
61. X.O. Yang, B.P. Pappu, R. Nurieva, A. Akimzhanov, H.S. Kang, and Y. Chung T helper 17 lineage differentiation is programmed by orphan nuclear receptors RORα and RORγ Immunity 28 2008 29 39
62. H-17 cells requires interferon-regulatory factor 4 Nat Immunol 8 2007 958 966 (Pubitemid 47300010)
63. H17 development by cooperating with ROR nuclear receptors Nature 464 2010 1381 1385
64. T. Muta IκB-ζ: an inducible regulator of nuclear factor-κB Vitam Horm 74 2006 301 316
65. M. Yamamoto, S. Yamazaki, S. Uematsu, S. Sato, H. Hemmi, and K. Hoshino Regulation of Toll/IL-1-receptor-mediated gene expression by the inducible nuclear protein IκBζ Nature 430 2004 218 222 (Pubitemid 38902431)
66. F. Zhang, G. Meng, and W. Strober Interactions among the transcription factors Runx1, RORγt and Foxp3 regulate the differentiation of interleukin 17-producing T cells Nat Immunol 9 2008 1297 1306
67. A.M. Akimzhanov, X.O. Yang, and C. Dong Chromatin remodeling of interleukin-17 (IL-17)-IL-17F cytokine gene locus during inflammatory helper T cell differentiation J Biol Chem 282 2007 5969 5972 (Pubitemid 47100812)
68. H. Takatori, Y. Kanno, Z. Chen, and J.J. O'Shea New complexities in helper T cell fate determination and the implications for autoimmune diseases Mod Rheumatol 18 2008 533 541
69. M. Mihara, Y. Ohsugi, and T. Kishimoto Evidence for the role of Th17 cell inhibition in the prevention of autoimmune diseases by anti-interluekin-6 receptor antibody Biofactors 35 2009 47 51
70. H17-cell-mediated autoimmunity to environmental toxins Nature 453 2008 106 109 (Pubitemid 351630329)
71. H17 cell differentiation by the aryl hydrocarbon receptor Nature 453 2008 65 71 (Pubitemid 351630328)
72. H17 differentiation Nature 460 2009 405 409